期刊
DIABETES-METABOLISM RESEARCH AND REVIEWS
卷 38, 期 6, 页码 -出版社
WILEY
DOI: 10.1002/dmrr.3556
关键词
biomarkers; diabetic kidney disease; inflammation; kidney injury; kidney injury Molecule-1 [KIM-1]; tumour necrosis factor receptor [TNFR]
资金
- University of Melbourne
- Austin Health
- Sir Edward Weary Dunlop Medical Research Foundation
- JDRF Australia
- Australian Research Council Special Research Initiative in Type 1 Juvenile Diabetes
Diabetic kidney disease is a growing concern, and there is a need to identify biomarkers that can accurately predict the risk of declining kidney function. Multiple serum and urine biomarkers of inflammation and kidney injury have shown significant association with the development and progression of diabetic kidney disease. Tumor necrosis factor receptor-1 and -2 appear to be promising markers for diabetic kidney disease, while kidney injury molecule-1, beta-2-microglobulin, and neutrophil gelatinase-associated lipocalin are potential candidates for markers of kidney injury.
Diabetic kidney disease is expected to increase rapidly over the coming decades with rising prevalence of diabetes worldwide. Current measures of kidney function based on albuminuria and estimated glomerular filtration rate do not accurately stratify and predict individuals at risk of declining kidney function in diabetes. As a result, recent attention has turned towards identifying and assessing the utility of biomarkers in diabetic kidney disease. This review explores the current literature on biomarkers of inflammation and kidney injury focussing on studies of single or multiple biomarkers between January 2014 and February 2020. Multiple serum and urine biomarkers of inflammation and kidney injury have demonstrated significant association with the development and progression of diabetic kidney disease. Of the inflammatory biomarkers, tumour necrosis factor receptor-1 and -2 were frequently studied and appear to hold most promise as markers of diabetic kidney disease. With regards to kidney injury biomarkers, studies have largely targeted markers of tubular injury of which kidney injury molecule-1, beta-2-microglobulin and neutrophil gelatinase-associated lipocalin emerged as potential candidates. Finally, the use of a small panel of selective biomarkers appears to perform just as well as a panel of multiple biomarkers for predicting kidney function decline.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据